Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Anido Armando was granted 43,164 shares and sold $13,089 worth of shares (11,899 units at $1.10), increasing direct ownership by 5% to 611,688 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.